tirzepatide vs semaglutide difference vs. Semaglutide: What You Should Know Semaglutide vs. Tirzepatide for weight

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)

Portion-controlled, protein- and fiber-rich options are increasingly marketed not as restrictive diet foods, but as tools to help individuals maintain nutritional adequacy within smaller eating windows

These researchers looked at kidney disease and cardiovascular disease

Graphic by Clara Turnage/University Marketing and Communications By Clara Turnage Campus Office, Department or Center Published July 21, 2026

Related possibly

GLP-1R agonists The GLP-1R agonists mediate their action by acting directly on the GLP-1R